AstraZeneca competitorsClear all

AstraZeneca's top competitors include Daiichi Sankyo, Boehringer Ingelheim, Sanofi, Novartis, GSK, Amgen, Bayer, Bristol-Myers Squibb and Teva Pharmaceuticals.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
AstraZeneca
AstraZeneca
AstraZeneca is a global science-led biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
Daiichi Sankyo
Daiichi Sankyo
Daiichi Sankyo (第一三共株式会社) is a developer of pharmaceutical products.
Boehringer Ingelheim
Boehringer Ingelheim
Boehringer Ingelheim International is a global pharmaceutical company engaged in human pharmaceuticals, animal health, and biopharmaceuticals businesses.
Sanofi
Sanofi
Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.
Novartis
Novartis
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
GSK
GSK
GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products.
Amgen
Amgen
Amgen (formerly known as Applied Molecular Genetics) is a biotech company discovering, developing, manufacturing, and delivering human therapeutics products.
Bayer
Bayer
Bayer is a global life science company specializing in healthcare and nutrition.
Bristol-Myers Squibb
Bristol-Myers Squibb
Bristol-Myers Squibb is a company focused that provides biopharmaceutical products.
Teva Pharmaceuticals
Teva Pharmaceuticals
Teva Pharmaceuticals is a global pharmaceutical company.
Founding Date
Founding Date
1999
Founding Date
2005
Founding Date
1885
Founding Date
2004
Founding Date
1996
Founding Date
2000
Founding Date
1980
Founding Date
1863
Founding Date
1887
Founding Date
1901
Type
Type
Public
Type
Public
Type
Subsidiary
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, GB HQ
Alger, DZ
Buenos Aires, AR
Haedo, AR
Macquarie Park, AU
Macquarie Park, AU
North Ryde, AU
see more
Locations
Tokyo, JP HQ
Wien, AT
Braine L'alleud, BE
Sao Paulo, BR
São Paulo, BR
Beijing, CN
Shanghai, CN
see more
Locations
Ingelheim am Rhein, DE HQ
Algiers, DZ
Munro, AR
Macquarie Park, AU
Vienna, AT
Minsk, BY
Elsene, BE
see more
Locations
Paris, FR HQ
Hydra, DZ
Macquarie Park, AU
Wien, AT
Dhaka, BD
Brussel, BE
Geel, BE
see more
Locations
Basel, CH HQ
Tirana, AL
Bir Mourad Raïs, DZ
Duc, AR
Macquarie Park, AU
Wien, AT
Baku, AZ
see more
Locations
Brentford, GB HQ
Boumerdes, DZ
San Fernando, AR
Abbotsford, AU
Ermington, AU
Wien, AT
Minsk, BY
see more
Locations
Thousand Oaks, US HQ
Hydra, DZ
Vicente López, AR
Sydney, AU
Wien, AT
Machelen, BE
Santo Amaro, BR
see more
Locations
Leverkusen, DE HQ
Tirana, AL
Dely Ibrahim, DZ
Luanda, AO
Munro, AR
Pymble, AU
Wien, AT
see more
Locations
New York, US HQ
Wien, AT
Braine L'alleud, BE
Bruxelles, BE
São Paulo, BR
Montréal, CA
Shanghai, CN
see more
Locations
Petah Tikva, IL HQ
Villa Adelina, AR
Macquarie Park, AU
Minsk, BY
Antwerpen, BE
São Paulo, BR
Dupnica, BG
see more
Employees
Employees
76,1008% increase
Employees
16,0334% increase
Employees
52,3911% increase
Employees
95,4424% decrease
Employees
110,0004% increase
Employees
90,0964% decrease
Employees
24,200
Employees
99,6372% decrease
Employees
32,2006% increase
Employees
37,100
Valuation ($)
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
143.8 b
Valuation ($)
N/A
Valuation ($)
169 b
Valuation ($)
N/A
Twitter followers
Twitter followers
299.8 k
Twitter followers
625
Twitter followers
104.8 k
Twitter followers
148 k
Twitter followers
300.1 k
Twitter followers
236.2 k
Twitter followers
105.4 k
Twitter followers
183.2 k
Twitter followers
155.8 k
Twitter followers
3.6 k
Number of tweets (last 30 days)
Number of tweets (last 30 days)
48
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
37
Number of tweets (last 30 days)
18
Number of tweets (last 30 days)
20
Number of tweets (last 30 days)
68
Number of tweets (last 30 days)
101
Number of tweets (last 30 days)
71
Number of tweets (last 30 days)
75
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
13.5
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
12.3
Average likes per tweet (last 30 days)
16.4
Average likes per tweet (last 30 days)
15.3
Average likes per tweet (last 30 days)
10.5
Average likes per tweet (last 30 days)
6.2
Average likes per tweet (last 30 days)
14.9
Average likes per tweet (last 30 days)
6.4
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
45%
Percentage of tweets with engagement (last 30 days)
89.71%
Percentage of tweets with engagement (last 30 days)
95.05%
Percentage of tweets with engagement (last 30 days)
64.79%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Alexa Website Rank
Alexa Website Rank
102516
Alexa Website Rank
560867
Alexa Website Rank
176211
Alexa Website Rank
178741
Alexa Website Rank
102511
Alexa Website Rank
15074
Alexa Website Rank
181163
Alexa Website Rank
77182
Alexa Website Rank
84900
Alexa Website Rank
338084
Employee Rating
Employee Rating
4.1
Employee Rating
3.9
Employee Rating
4.2
Employee Rating
3.9
Employee Rating
4.2
Employee Rating
3.9
Employee Rating
4.1
Employee Rating
4.3
Employee Rating
3.9
Employee Rating
3.6

Financial

Revenue (est.)
Revenue (est.)
$37.4b (FY, 2021)
Revenue (est.)
¥981.8b (FY, 2019)
Revenue (est.)
€20.6b (FY, 2021)
Revenue (est.)
€37.8b (FY, 2021)
Revenue (est.)
$52.9b (FY, 2021)
Revenue (est.)
£34.1b (FY, 2021)
Revenue (est.)
$26b (FY, 2021)
Revenue (est.)
€44.1b (FY, 2021)
Revenue (est.)
$46.4b (FY, 2021)
Revenue (est.)
$15.9b (FY, 2021)
Cost of goods
Cost of goods
($5.9b) (FY, 2021)
Cost of goods
¥343.2b (FY, 2019)
Cost of goods
€2.8b (FY, 2021)
Cost of goods
(€10.7b) (FY, 2021)
Cost of goods
($9.7b) (FY, 2021)
Cost of goods
£11.6b (FY, 2021)
Cost of goods
$6.5b (FY, 2021)
Cost of goods
(€11.7b) (FY, 2021)
Cost of goods
$9.9b (FY, 2021)
Cost of goods
($7b) (FY, 2021)
Gross profit
Gross profit
$32b (FY, 2021)
Gross profit
¥638.6b (FY, 2019)
Gross profit
€17.8b (FY, 2021)
Gross profit
€28.9b (FY, 2021)
Gross profit
$45.1b (FY, 2021)
Gross profit
£22.5b (FY, 2021)
Gross profit
$19.5b (FY, 2021)
Gross profit
€33.6b (FY, 2021)
Gross profit
$36.4b (FY, 2021)
Gross profit
$9b (FY, 2021)
Net income
Net income
$115m (FY, 2021)
Net income
¥129b (FY, 2019)
Net income
€3.4b (FY, 2021)
Net income
€6.2b (FY, 2021)
Net income
$24b (FY, 2021)
Net income
£5.1b (FY, 2021)
Net income
$5.9b (FY, 2021)
Net income
€1b (FY, 2021)
Net income
$7b (FY, 2021)
Net income
$447m (FY, 2021)

Operating

Countries
Countries
100 (FY, 2020)
Countries
N/A
Countries
N/A
Countries
N/A
Countries
N/A
Countries
92 (FY, 2021)
Countries
100 (FY, 2020)
Countries
153 (FY, 2018)
Countries
N/A
Countries
N/A
Facilities
Facilities
N/A
Facilities
N/A
Facilities
N/A
Facilities
N/A
Facilities
N/A
Facilities
N/A
Facilities
180 (FY, 2020)
Facilities
N/A
Facilities
N/A
Facilities
90 (FY, 2019)
Manufacturing Facilities
Manufacturing Facilities
N/A
Manufacturing Facilities
13 (Dec, 2020)
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
N/A
Manufacturing Facilities
7 (FY, 2020)
Manufacturing Facilities
N/A
Patent Applications
Patent Applications
N/A
Patent Applications
415 (Dec, 2020)
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
N/A
Patent Applications
48.1 k (FY, 2017)
Patent Applications
N/A
Patent Applications
N/A
Phase I Trials Products
Phase I Trials Products
N/A
Phase I Trials Products
16 (FY, 2019)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
16 (FY, 2021)
Phase I Trials Products
20 (FY, 2020)
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products
N/A
Phase I Trials Products (Oncology)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
9 (FY, 2021)
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
N/A
Phase I Trials Products (Oncology)
22 (FY, 2020)
Phase I Trials Products (Oncology)
N/A
Phase II Trials Products
Phase II Trials Products
N/A
Phase II Trials Products
7 (FY, 2019)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products
6 (FY, 2021)
Phase II Trials Products
5 (FY, 2020)
Phase II Trials Products
12 (Jan, 2020)
Phase II Trials Products
N/A
Phase II Trials Products
N/A
Phase II Trials Products (Oncology)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
12 (FY, 2021)
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
N/A
Phase II Trials Products (Oncology)
13 (FY, 2020)
Phase II Trials Products (Oncology)
N/A
Phase III Trials Products
Phase III Trials Products
N/A
Phase III Trials Products
7 (FY, 2019)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products
54 (FY, 2021)
Phase III Trials Products
11 (FY, 2021)
Phase III Trials Products
11 (FY, 2020)
Phase III Trials Products
9 (Jan, 2020)
Phase III Trials Products
N/A
Phase III Trials Products
N/A
Phase III Trials Products (Oncology)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
27 (FY, 2021)
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
N/A
Phase III Trials Products (Oncology)
6 (FY, 2020)
Phase III Trials Products (Oncology)
N/A
Projects in R&D Pipeline
Projects in R&D Pipeline
171 (FY, 2020)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
91 (FY, 2019)
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Projects in R&D Pipeline
N/A
Suppliers
Suppliers
N/A
Suppliers
N/A
Suppliers
N/A
Suppliers
68 k (FY, 2019)
Suppliers
N/A
Suppliers
37.5 k (FY, 2021)
Suppliers
N/A
Suppliers
86.4 k (FY, 2019)
Suppliers
N/A
Suppliers
N/A

Funding

Total funding raised
Total funding raised
$ 1b
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 310m
Total funding raised
$ 6.5m
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 3.5b
Total funding raised
$ 15.5m
Total funding raised
$ 358m
For sources of this data, please see the company profile

View company profiles

Daiichi Sankyo
HQ
Tokyo, JP
Employees
16,033↑ 4% increase

Daiichi Sankyo (第一三共株式会社) is a developer of pharmaceutical products.

View company
Boehringer Ingelheim
HQ
Ingelheim am Rhein, DE

Boehringer Ingelheim International is a global pharmaceutical company engaged in human pharmaceuticals, animal health, and biopharmaceuticals businesses.

View company
Sanofi
HQ
Paris, FR
Employees
95,442↓ 4% decrease

Sanofi is a global healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions.

View company
Novartis
HQ
Basel, CH
Employees
110,000↑ 4% increase

Novartis is a company that researches, develops, manufactures, and markets healthcare products.

View company